1Hallis B, Siman N J, Noonan S, et al. Novel in vitro functional assays for the determination of anthrax toxin components [J]. Dev Biol( Basel)2002, 111:321-326.
2Jernigan JA,Stephens DS,Ashford DA, et al. Bioterrorism-related inhalational anthrax; the first 10 cases reported in the United States [J]. Emerg Infect Dis 2001,7(6) :933-944.
4Kalpadakis P, Rudolph G,Stefani fH, et al. Anthrax-an old disease becomes topical: cutaneous anthrax and the eye [J]. Ophthalmologe 2003, 100(3) :2i6=221.
5Freedman A, Afonia O, Chang MW, et al. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infat[J], JAMA 2002,287(7) :869-874.
6Catucci JA, McGovern TW, Norton SA, et al, Cutaneous anthrax management algorithm[J], J Am Acad Dermatol 2002, 47(5):766-769.
7Pande H, Lscy BE, Crowell MD. Lanflammatory causes of gastroparesis: report drive cases [J]. Dig Dis Sci 2002,47(12):26664-26668.
8Rosenthal SR, Clifford JC. Development of vaccines for bio-warfare agents[J]. Dev Biol (Basel)2002,110:99-105.
9Weber DJ, Sickbed-Bennett E, Gergen MF, et al. Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus(a surrogate of Bacillus anthracis)from contaminated hands[J].JAMA 2003, 289 (10) : 1274-1277.
10Ingleshy TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management.working group on cibilian biodefense[J].JAMA,199,281(18):1735-1745.
